Neonatal Hyperbilirubinemia
Conditions
Brief summary
Hyperbilirubinemia is the most common problem seen in neonates, owing to severe complications in their lifetime. The study design of the study is pretest - a posttest experimental design. Criterion-based purposive sampling will be used for recruiting the neonates. In the study neonates will be selected according to the selection criteria and will be allocated into two groups using computer-based randomization.The Intervention group - neonates will receive tactile and kinesthetic stimulation for 15 minutes for 3 consecutive days, 1 hour after feeding twice daily along with Phototherapy, Control group - Phototherapy alone will be given along with conventional NICU care. Total serum bilirubin will be assessed as outcome measures daily once. Transcutaneous bilirubin will be assessed after every intervention.
Interventions
OTHERMassage therapy
Massage therapy includes stroking, kneading, rolling, tapping, vibration and effleurage over the face, chest ,abdomen and back. Massage therapy will be given for 5 minutes and will be repeated twice.
OTHERKinaesthetic stimulation
Kinaesthetic stimulation includes passive flexion and extension movements of shoulder joint, elbow joint, hip joint, knee joint and both lower limbs together. It will be given for 5 minutes in each intervention
Sponsors
Asir John Samuel
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
24 Hours to 10 Days
Healthy volunteers
Yes
Inclusion criteria
1. New born in Neonatal Intensive Care Unit 2. Stable vitals 3. Full Term and Preterm neonates 4. Gestational age 34 weeks to 40 weeks 5. Birth weight -1800 - 3000 g 6. APGAR Score at birth of 8 -10 7. Total serum bilirubin levels \> 10 mg/dL
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total Serum Bilirubin (TSB) | Changes in the Total Serum Bilirubin level will be measured at baseline and at the end of three days intervention | It will measure total bilirubin level in blood of neonates |
| Transcutaneous Bilirubin (TcB) | Changes in the Transcutaneous Bilirubin level will be measured daily for three days before and after intervention | Transcutaneous Bilirubin will measure neonatal jaundice. |
| Weight Gain | Changes in the weight will be measured at baseline and at the end of three days intervention | Weight gain will evaluate the change in neonatal weight |
Countries
India
Outcome results
None listed